98%
921
2 minutes
20
Background: Various methods have been used to identify substrate of persistent atrial fibrillation (PeAF) including complex fractionated atrial electrograms (CFAEs), electrogram dispersion, and low-voltage areas (LVAs). This study aims to investigate their relationship and changes following ablation.
Methods And Results: Consecutive patients with PeAF undergoing catheter ablation were prospectively recruited. High-density left atrial mapping was employed. Repeat mapping was performed after pulmonary vein and posterior wall isolation (PVI + PWI) if atrial fibrillation persisted. Dispersion tags were automatically annotated using a commercially available artificial intelligence system. A total of 32 patients (mean age 64.8 ± 9.7 years, 26 male) were included. In CFAE regions, 93.1 ± 7.5% of the surface had voltage > 0.5 mV, compared to only 17.5 ± 24.5% in the non-CFAE regions. Nearly all dispersion tags (99.3 ± 1.6%) were located within CFAE regions. Postablation mapping (N = 24) revealed a reduction in both CFAE and dispersion tags, prolongation of atrial cycle length, and de-escalation of CFAE sub-types, even in areas remote from ablation targets. During a median follow-up period of 9.0 ± 1.9 months, among the nine patients with CFAE de-escalations across all five regions, only one (11.1%) experienced recurrence. In contrast, eight out of the remaining 15 patients (53.3%) experienced recurrence (p = 0.039).
Conclusion: Dispersion is associated with CFAEs, predominantly reflecting areas of normal voltage. Regional reductions in CFAE and dispersion burden may occur outside of the directly targeted ablation areas. Post-procedural de-escalation of electrograms across the left atrium might suggest a potential indicator for PVI + PWI responders; however, further studies are warranted.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jce.16738 | DOI Listing |
JAMA Netw Open
September 2025
City St George's, University of London, London, UK.
JAMA Netw Open
September 2025
Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock.
Importance: Patients with kidney failure (KF) receiving long-term dialysis have increased incidence of atrial fibrillation (AF). Patients with KF and AF have increased risk of stroke, death, and bleeding compared with age-matched cohorts. In KF, the use of oral anticoagulants (OACs) increases hemorrhage risk, offsetting potential benefits and making left atrial appendage occlusion (LAAO) a potentially promising solution for risk reduction in AF.
View Article and Find Full Text PDFEur J Prev Cardiol
September 2025
Department of Cardiology, Esbjerg and Grindsted Hospital - University Hospital of Southern Denmark, Esbjerg, Denmark.
Aim: This study aimed to establish general consensus on a systematic needs assessment model to determine eligibility for cardiac rehabilitation (CR) as part of secondary prevention in individuals with atrial fibrillation (AF). Specific objectives included identifying relevant needs assessment criteria and establishing consensus on referral criteria.
Methods: A Delphi study was conducted following the ACCORD guidelines (ACcurate COnsensus Reporting Document) with participation of an international, multi-disciplinary expert panel including physicians, nurses and other healthcare professionals, across primary and secondary care as well as academic research.
Int J Pharm Pract
September 2025
Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Suthep Road, Suthep, Mueang, Chiang Mai 50200, Thailand.
Objectives: Proton pump inhibitors (PPIs) are commonly used among these patients to prevent upper gastrointestinal bleeding (UGIB) in anticoagulated patients. However, their clinical benefits among patients receiving OACs with a history of UGIB remain inconclusive. This study aimed to summarize the clinical benefits of PPIs for the secondary prevention of recurrent UGIB among patients using OACs.
View Article and Find Full Text PDFJACC Case Rep
September 2025
Division of Academic Affairs and Research, Orlando Regional Medical Center, Orlando, Florida, USA. Electronic address:
Background: Tachycardia-induced cardiomyopathy (TICM) is typically reversible with rhythm control, but individual susceptibility remains poorly understood and may reflect genetic predisposition.
Case Summary: A 66-year-old woman with paroxysmal atrial fibrillation (AF) presented with new-onset heart failure. Genetic testing identified a likely pathogenic heterozygous ABCC9 gene variant (c.